- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces First Quarter 2024 Results
- Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
More ▼
Key statistics
As of last trade, Enovis Corp (ENOV:NYQ) traded at 50.54, 17.41% above the 52 week low of 43.04 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 50.65 |
---|---|
High | 51.10 |
Low | 50.53 |
Bid | 50.41 |
Offer | 50.63 |
Previous close | 51.04 |
Average volume | 495.75k |
---|---|
Shares outstanding | 54.85m |
Free float | 51.69m |
P/E (TTM) | -- |
Market cap | 2.80bn USD |
EPS (TTM) | -1.89 USD |
Data delayed at least 15 minutes, as of May 23 2024 14:51 BST.
More ▼